Novel piperazine and homopiperazine derivative and preparation method and use thereof

A technology of piperazine and compound, applied in the field of pharmaceutical compositions containing the above substances, can solve problems such as poor water solubility, limited clinical application and the like

Inactive Publication Date: 2012-04-11
GUANGXI NORMAL UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these drugs have poor water solubility, which

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel piperazine and homopiperazine derivative and preparation method and use thereof
  • Novel piperazine and homopiperazine derivative and preparation method and use thereof
  • Novel piperazine and homopiperazine derivative and preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0108] Example 1: 1-methyl-4-(10-acetoxy-2-decenoyl) piperazine (compound 1 ) preparation

[0109] Step 1: Preparation of 10-acetoxy-2-decenoic acid

[0110]

[0111] Under stirring conditions, 10-hydroxy-2-decenoic acid (9.30 g, 50 mmol) and acetic anhydride (9.43 mL, 100 mmol) were successively added to a 50 mL dry round-bottomed flask, and the above mixture was added at 100 ° Heat to reflux in C oil bath for 1 h. The reaction solution was concentrated under reduced pressure, and the obtained crude product was subjected to silica gel column chromatography (eluent: V 丙酮 : V 石油醚 = 1:20) separation and purification to obtain 9.51 g of pale yellow oily liquid with a yield of 83.4%.

[0112] Step 2: 1-methyl-4-(10-acetoxy-2-decenoyl) piperazine (compound 1 ) preparation

[0113]

[0114] 1

[0115] 10-Acetoxy-2-decenoic acid (2.28 g, 10 mmol) and dichloromethane (30 mL) were added to a 50 mL round bottom flask, and SOCl was added dropwise with stirring 2 (1.46 m...

Embodiment 2

[0116] Example 2: 1-ethyl-4-(10-acetoxy-2-decenoyl)piperazine (compound 2 ) preparation

[0117] 2

[0118] The method was the same as that of the intermediate example 1, and ethylpiperazine was substituted for methylpiperazine to obtain 5.56 g of light yellow oily liquid with a yield of 85.8%. 1 H NMR (CD 3 OD, 500 MHz) δ : 6.86~6.70 (m, 1H, C H =CHCO), 6.45 (d, J =14.9 Hz, 1H, CH=C H CO), 4.07 (t, J =6.7 Hz, 2H, OC H 2 –(CH 2 ) 5 –CH 2 ), 3.68 (t, J =5.0 Hz, 4H, (C H 2 ) 2 NC 2 h 5 ), 2.55~2.45 (m, 6H, CON(C H 2 ) 2 and NC H 2 CH 3 ), 2.30~2.24 (m, 2H, OCH 2 –(CH 2 ) 5 –C H 2 ), 2.05 (s, 3H, C H 3 CO 2 ), 1.68~1.35 (m, 10H, OCH 2 –(C H 2 ) 5 –CH 2 ), 1.14 (t, J =7.2 Hz, 3H, NCH 2 C H 3 ); 13 C NMR (CD 3 OD, 125MHz) δ : 171.6, 166.3, 146.8, 119.9, 64.3, 52.7, 52.1, 51.8, 45.2, 41.5, 32.1, 28.8, 28.7, 28.6, 28.3, 25.6, 19.7, 10.7; ESI-MS m / z : 325.23 (M+1) + ; IR (KBr, cm –1 ) ν: 1738 (C=O), 1659 (C=O), 1...

Embodiment 3

[0119] Example 3: 1-hexyl-4-(10-acetoxy-2-decenoyl)piperazine (compound 3 ) preparation

[0120] 3

[0121] Method is the same as intermediate embodiment 1, and hexylpiperazine is replaced methylpiperazine, and the thick product of gained is with silica gel column chromatography (eluent: V 甲醇 : V 乙酸乙酯 =1:2) separation and purification to obtain 5.92 g of light yellow oily liquid with a yield of 77.8%. 1 H NMR (DMSO- d 6 , 500 MHz) δ : 6.69~6.10 (m, 1H, C H =CHCO), 6.44 (d, J =15.0 Hz, 1H, CH=C H CO), 4.06 (t, J =6.6 Hz, 2H, OC H 2 –(CH 2 ) 5 –CH 2 ), 3.55~3.45 (m, 4H, (C H 2 ) 2 N(CH 2 ) 5 CH 3 ), 2.35~2.23 (m, 6H, CON(C H 2 ) 2 and NC H 2 –(CH 2 ) 4 –CH 3 ), 2.21~2.14 (m, 2H, OCH 2 –(CH 2 ) 5 –C H 2 ), 2.00 (s, 3H, C H 3 CO 2 ), 1.60~1.22 (m, 18H, OCH 2 –(C H 2 ) 5 –CH 2 and NCH 2 –(C H 2 ) 4 –CH 3 ), 0.87 (t, J =6.5 Hz, 3H, NCH 2 –(CH 2 ) 4 –C H 3 ); 13 C NMR (DMSO- d 6 , 125MHz) δ : 170.8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound of formula I or pharmaceutically acceptable salt and a preparation method thereof, as well as a drug composition containing the same. The compound of formula I is novel piperazine and homopiperazine derivative, which can be used for preparing cervical cancer-treating medicine, anti-acetylcholinesterase and butyrylcholinesterase medicine, and medicine for treating staphylococcus aureus infection.

Description

technical field [0001] The present invention relates to novel piperazine and homopiperazine derivatives, or pharmaceutically acceptable salts and solvates thereof, a preparation method thereof, and a pharmaceutical composition containing the above substances. Background technique [0002] Piperazine, also known as hexahydropyrazine, is a six-membered heterocyclic ring containing two nitrogen atoms in the molecule. It has high formation enthalpy and good thermal stability. It is an ideal structural unit of nitrogen-rich heterocyclic compounds and an important component of many drugs. part. Compared with traditional organic drugs, piperazine compounds have a better nitrogen balance symmetrical structure. The introduction of piperazine ring in organic synthesis as a synergistic group of drugs can improve the pharmacokinetic properties of drugs and increase the biological activity of drugs. [0003] Different substituents are introduced on the piperazine ring. Due to the diffe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D295/185A61K31/551A61K31/495A61P35/00A61P35/02A61P25/28A61P31/02A61P31/04
Inventor 苏桂发郑志兵农娟李松王莉莉覃江克潘成学唐煌邓业成
Owner GUANGXI NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap